Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content

Diabetes

Volumn 52, Issue 3, 2003, Pages 701-707

  Tiikkainen, Mirja ^a   Bergholm, Robert ^a   Vehkavaara, Satu ^a   Rissanen, Aila ^a   Häkkinen, Anna Maija ^a   Tamminen, Marjo ^a   Teramo, Kari ^a   Yki Järvinen, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ALT, alanine aminotransferase; FFA, free fatty acid; IMCL, intramyocellular lipid; LFAT, liver fat; MRI, magnetic resonance imaging

Indexed keywords

FATTY ACID; INSULIN; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY COMPOSITION; CALORIC INTAKE; CLINICAL ARTICLE; DIETARY INTAKE; FAT CONTENT; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID STORAGE; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; SPECTROSCOPY; SUBCUTANEOUS FAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ADIPOSE TISSUE; ADULT; ALANINE TRANSAMINASE; BLOOD PRESSURE; BODY COMPOSITION; BODY CONSTITUTION; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 0037342842     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.3.701     Document Type: Article

References (59)

1. Kim JK, Gavrilova O, Chen Y, Reitman ML, Shulman GI: Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275:8456-8460, 2000
2. Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S, Graves RA: Troglitazone action is independent of adipose tissue. J Clin Invest 100:2900-2908, 1997
3. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, Koder A, Evans RM: PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 4:585-595, 1999
4. Shimomura I, Hammer RE, Richardson JA, Ikemoto S, Bashmakov Y, Goldstein JL, Brown MS: Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12:3182-3194, 1998
5. Virkamäki A, Korsheninnikova E, Seppälä-Lindroos A, Vehkavaara S, Goto T, Halavaara J, Häkkinen AM, Yki-Järvinen H: Intramyocellular lipid is associated with resistance to in vivo insulin actions on glucose uptake, antilipolysis, and early insulin signaling pathways in human skeletal muscle. Diabetes 50:2337-2343, 2001
6. Bachmann OP, Dahl M, Brechtel K, Machann J, Haap M, Maier T, Loviscach M, Stumvoll M, Claussen CD, Schick F, Haring HU, Jacob S: Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 50:2579-2584, 2001
7. Brechtel K, Dahl DB, Machann J, Bachmann OP, Wenzel I, Maier T, Claussen CD, Haring HU, Jacob S, Schick F: Fast elevation of the intramyocellular lipid content in the presence of circulating free fatty acids and hyperinsulinemia: a dynamic 1H-MRS study. Magn Reson Med 45:179-183, 2001
8. Krssak M, Falk PK, Dresner A, DiPietro L, Vogel SM, Rothman DL, Roden M, Shulman GI: Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study. Diabetologia 42:113-116, 1999
9. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH: Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46:983-988, 1997
10. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, Goto T, Westerbacka J, Sovijärvi A, Halavaara J, Yki-Järvinen H: Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab 87:3023-3028, 2002
11. Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H: Rosiglitatzone in the treatment of HAART-associated lipodystrophy: a randomized placebo-controlled study. Antivir Ther. In press
12. Gavrilova O, Marcus-Samuels B, Graham D, Kim JK, Shulman GI, Castle AL, Vinson C, Eckhaus M, Reitman ML: Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest 105:271-278, 2000
13. Arner P: Regional adipocity in man (Review). J Endocrinol 155:191-192, 1997
14. Frayn KN: Visceral fat and insulin resistance: causative or correlative? Br J Nutr 83 (Suppl 1):S71-S77, 2000
15. Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV: Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49:2017-2036, 1970
16. Martin ML, Jensen MD: Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest 88:609-613, 1991
17. Guo Z, Hensrud DD, Johnson CM, Jensen MD: Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48:1586-1592, 1999
18. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL: Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 48:839-847, 1999
19. Watts GF, Herrmann S, Riches FM: Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men. QJM 93:153-161, 2000
20. Fujioka S, Matsuzawa Y, Tokunaga K, Kawamoto T, Kobatake T, Keno Y, Kotani K, Yoshida S, Tarui S: Improvement of glucose and lipid metabolism associated with selective reduction of intra-abdominal visceral fat in premenopausal women with visceral fat obesity. Int J Obes 15:853-859, 1991
21. Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS: Effect of weight loss with reduction of intra-abdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab 85:977-982, 2000
22. Doucet E, St-Pierre S, Almeras N, Imbeault P, Mauriege P, Pascot A, Despres JP, Tremblay A: Reduction of visceral adipose tissue during weight loss. Eur J Clin Nutr 56:297-304, 2002
23. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A: Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab 64:661-668, 1987
24. Olsson SA, Petersson BG, Sorbris R, Nilsson-Ehle P: Effects of weight reduction after gastroplasty on glucose and lipid metabolism. Am J Clin Nutr 40:1273-1280, 1984
25. Ranlov I, Hardt F: Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 47:208-214, 1990
26. Luyckx FH, Desaive C, Thiry A, Dewe W, Scheen AJ, Gielen JE, Lefebvre PJ: Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. Int J Obes Relat Metab Disord 22:222-226, 1998
27. Silverman EM, Sapala JA, Appelman HD: Regression of hepatic steatosis in morbidly obese persons after gastric bypass. Am J Clin Pathol 104:23-31, 1995
28. Busetto L, Tregnaghi A, De Marchi F, Segato G, Foletto M, Sergi G, Favretti F, Lise M, Enzi G: Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res 10:408-411, 2002
29. Drenick EJ, Simmons F, Murphy JF: Effect on hepatic morphology of treatment of obesity by fasting, reducing diets and small-bowel bypass. N Engl J Med 282:829-834, 1970
30. Andersen T, Gluud C, Franzmann MB, Christoffersen P: Hepatic effects of dietary weight loss in morbidly obese subjects, J Hepatol 12:224229, 1991
31. Alberti KG, Zimmet PZ: Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553, 1998
32. de Beer R, van den Boogaart A, van Ormondt D, Pijnappel WW, den Hollander JA, Marien AJ, Luyten PR: Application of time-domain fitting in the quantification of in vivo 1H spectroscopic imaging data sets. NMR Biomed 5:171-178, 1992
33. van der Veen, de Beer R, Luyten PR, van Ormondt D: Accurate quantification of in vivo 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 6:92-98, 1988
34. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O: Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 12:487-495, 1994
35. Szczepaniak LS, Babcock EE, Schick F, Dobbins RL, Garg A, Burns DK, McGarry JD, Stein DT: Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 276:E977-E989, 1999
36. Longo R, Pollesello P, Ricci C, Masutti F, Kvam BJ, Bercich L, Croce LS, Grigolato P, Paoletti S, de Bernard B: Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatesis. J Magn Reson Imaging 5:281-285, 1995
37. Sutinen J, Häkkinen AM, Westerbacka J, Seppälä-Lindroos A, Vehkavaara S, Halavaara J, Järvinen A, Ristola M, Yki-Järvinen H: Increased fat accumulation in the liver in HIV-infected patients with antiretroviral therapy-associated lipodystrophy. AIDS 16:2183-2193, 2002
38. Ryysy L, Häkkinen AM, Goto T, Vehkavaara S, Westerbacka J, Halavaara J, Yki-Järvinen H: Hepatic fat content and insulin action on free fatty acids and glucose metabolism rather than insulin absorption are associated with insulin requirements during insulin therapy in type 2 diabetic patients. Diabetes 49:749-758, 2000
39. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 41:810-817, 1985
40. Marti B, Tuomilehto J, Salomaa V, Kartovaara L, Korhonen HJ, Pietinen P: Body fat distribution in the Finnish population: environmental determinants and predictive power for cardiovascular risk factor levels. J Epidemiol Community Health 45:131-137, 1991
41. Kadish AH, Hall DA: A new method for the continuous monitoring of blood glucose by measurement of dissolved oxygen. Clin Chem 11:869-875, 1965
42. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738, 1971
43. Stenman UH, Pesonen K, Ylinen K, Huhtala ML, Teramo K: Rapid chromatographic quantitation of glycosylated haemoglobins. J Chromatogr 297:327-332, 1984
44. Miles J, Glasscock R, Aikens J, Gerich J, Haymond M: A microfluorometric method for the determination of free fatty acids in plasma. J Lipid Res 24:96-99, 1983
45. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
46. Thorne A, Lounqvist F, Apelman J, Hellers G, Arner P: A pilot study of long term effects of a novel obesity treatment: omentectomy in connection with adjustable gastric banding. Int J Obes Relat Metab Disord 26:193-199, 2002
47. Gibbons GF, Islam K, Pease RJ: Mobilisation of triacylglycerol stores. Biochim Biophys Acta 1483:37-57, 2000
48. Duee PH, Pegorier JP, el Manoubi L, Herbin C, Kohl C, Girard J: Hepatic triglyceride hydrolysis and development of ketogenesis in rabbits. Am J Physiol 249:E478-E484, 1985
49. Van Harken DR, Dixon CW, Heimberg M: Hepatic lipid metabolism in experimental diabetes V. The effect of concentration of oleate on metabolism of triglycerides and on ketogenesis. J Biol Chem R 244:2278-2285, 1969
50. Sidossis LS, Mittendorfer B, Walser E, Chinkes D, Wolfe RR: Hyperglycemia-induced inhibition of splanchnic fatty acid oxidation increases hepatic triacylglycerol secretion. Am J Physiol 275:E798-E805, 1998
51. Groop LC, Saloranta C, Shank M, Bonadonna RC, Ferrannini E, DeFronzo RA: The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 72:96-107, 1991
52. Shimomura I, Bashmakov Y, Horton JD: Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus. J Biol Chem 274:30028-30032, 1999
53. Reue K, Xu P, Wang XP, Slavin BG: Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouso fatty liver dystrophy (fld) gene. J Lipid Res 41:1067-1076, 2000
54. Moitra J, Mason MM, Olive M, Krylov D, Gavrilova O, Marcus-Samuels B, Feigenbaum L, Lee E, Aoyama T, Eckhaus M, Raitman ML, Vinson C: Life without white fat: a transgenic mouse. Genes Dev 12:3168-3181, 1998
55. Zimmerman HJ: Studies of the liver in diabetes mellitus. J Lab Clin Med 36:922-927, 1950
56. Galambos JT, Wills CE: Relationship between 505 paired liver tests and biopsies in 242 obese patients. Gastroenterology 74:1191-1195, 1978
57. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, Granzotto M, Vettor R, Camastra S, Ferrannini E: Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 51:144-151, 2002
58. Bruning JC, Michael MD, Winnay JN, Hayashi T, Horsch D, Accili D, Goodyear LJ, Kahn CR: A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance. Mol Cell 2:559-569, 1998
59. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97, 2000